Latest Nanoform News & Updates

See the latest news and media coverage for Nanoform. We track all announcements, press releases, and industry mentions in real time, all in one place.

Company icon
Nanoform

Nanotechnology drug particle engineering services provider

nanoform.com
Headquarters
Helsinki, Finland
Founded year
2015
Company type
Public company
Number of employees
125–200

Last updated

Latest news about Nanoform

In short: Nanoform reported significant 2025 revenue growth, finalized job reductions to cut costs, and delayed its nanoenzalutamide regulatory filing.

Company announcements

  • Nanoform

    Nanoform holds Annual General Meeting

    Approves financial statements, no dividend, re-elects board members, authorizes share repurchases and issuances. 35 shareholders represent 41.5% of shares.

  • Nanoform

    Nanoform announces delay in nanoenzalutamide MAA submission

    Feedback from European scientific advice meeting requires evaluating alternative regulatory pathways, postponing the May 2026 filing. Updated timelines will follow.

  • Nanoform

    Nanoform issues notice for Annual General Meeting

    The AGM convenes on April 21, 2026, in Helsinki to address financial statements, board elections, remuneration, and share authorizations. No dividend proposed.

  • Nanoform

    Nanoform publishes peer-reviewed study on nanocrystal technology

    In collaboration with Pion Inc., it demonstrates predictive power for nanoformed APIs using D-P data and in silico modeling.

Unlock all announcements with a

Media coverage

Unlock all articles with a

Never miss news about Nanoform

Track Nanoform and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.

Trending companies

Discover what's making headlines across other trending companies.